Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Becton Dickinson and Co
XMUN:BOX
|
US |
|
W
|
Wise Group PLC
F:6WS0
|
UK |
|
Tlou Energy Ltd
ASX:TOU
|
AU |
|
B
|
Baxter International Inc
XHAM:BTL
|
US |
|
T
|
Travelers Companies Inc
XHAN:PA9
|
US |
|
Banyan Gold Corp
F:BAJ
|
CA |
|
A
|
APG SGA SA
SWB:279
|
CH |
BDX has historically combined steady medical-device revenue growth with operating leverage and substantial operating cash generation. The model requires ongoing manufacturing investment, while acquisition, restructuring, remediation, and separation-related items make GAAP earnings more variable than cash flow.
The latest supplied quarter shows softer revenue, operating margin, and common earnings, but the comparison is affected by the 2026 portfolio separation and trailing cash generation remains positive. That points to a meaningful reporting and earnings-quality development rather than a demonstrated break in the underlying cash model.
Whether post-separation comparable revenue and operating margin stabilize while TTM operating cash flow remains positive.
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.5B | 12.1B | 16B | 17.3B | 16.1B | 19.1B | 18.9B | 19.4B | 20.2B | 21.8B | |
| (6.5B) | (6.1B) | (8.7B) | (9B) | (8.9B) | (10.4B) | (10.3B) | (10.5B) | (11B) | (11.8B) | |
| 6B | 6B | 7.3B | 8.3B | 7.1B | 8.7B | 8.6B | 8.8B | 9.2B | 10B | |
| (3.9B) | (4.1B) | (5.2B) | (6.1B) | (5.6B) | (6.4B) | (6B) | (6B) | (6.3B) | (6.5B) | |
| (3B) | (2.9B) | (4.1B) | (4.4B) | (4.2B) | (4.7B) | (4.7B) | (4.7B) | (4.9B) | (5.3B) | |
| (828m) | (770m) | (1B) | (1.1B) | (1B) | (1.3B) | (1.3B) | (1.2B) | (1.2B) | (1.2B) | |
| — | (410m) | 0 | (654m) | (363m) | (362m) | (18m) | (44m) | (210m) | (1m) | |
| 2.1B | 1.9B | 2.1B | 2.2B | 1.6B | 2.3B | 2.6B | 2.8B | 2.9B | 3.5B | |
| (370m) | (432m) | (359m) | (626m) | (501m) | (373m) | (491m) | (442m) | (407m) | (627m) | |
| 388m | 521m | 706m | 639m | 528m | 469m | 398m | 452m | 528m | 613m | |
| (689m) | (417m) | (626m) | (454m) | (649m) | (255m) | (329m) | (653m) | (483m) | (944m) | |
| 14m | (41m) | 39m | 66m | 11m | (7m) | (17m) | (66m) | (11m) | (57m) | |
| 1.1B | 976m | 1.2B | 1.2B | 414m | 1.7B | 1.8B | 1.7B | 2B | 1.9B | |
| (97m) | 124m | (222m) | 7m | (62m) | (88m) | (148m) | (132m) | (300m) | (203m) | |
| 977m | 1.1B | 951m | 1.2B | 352m | 1.6B | 1.6B | 1.5B | 1.7B | 1.7B | |
| 976m | 1B | 159m | 1.1B | 767m | 2B | 1.7B | 1.4B | 1.7B | 1.7B | |
| 4.49 | 4.61 | 0.60 | 3.93 | 2.71 | 6.85 | 5.87 | 4.93 | 5.86 | 5.82 |
© 2026 Alpha Spread Limited. All Rights Reserved.
www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more